Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says

Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says his role will have limited impact.